← The library
Lemon Bottle
lipolytic injection solutionNot a peptide · cosmetic solutionMetabolic/WeightEvidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
PurposeMetabolic / Weight
MechanismMarketed as an injectable lipolytic solution; the manufacturer lists riboflavin (vitamin B2) among the actives, whose role in fat breakdown by injection is theoretical rather than established.
EffectsMarketed for dissolving localised pockets of fat. No independent peer-reviewed randomised trial supports the formulation.
DosingNo human dose established.
Bottom lineAn unapproved injectable with an FDA warning letter behind it and no published trial in front of it.
Batches on filenone
No tested batches on file.
Read with
The library records no pairings for this entry.
Cautions & interactions
The FDA issued a warning letter in March 2025 over US sale of Lemon Bottle and similar injectables as unapproved new drugs. Reported complications include injection-site infection, skin necrosis, persistent nodules, asymmetric contouring, permanent scarring and allergic reaction.
Composition is not fully disclosed, so interactions cannot be assessed.
CV 1 of 5 — No cardiovascular data of any kind.